4ο Conference of Transcatheter Therapies for Structural Heart Diseases
and pre-conference seminar for Trainees and Young Cardiologists
Athens, May 14-16, 2015
Under the hospices of
 Hellenic Cardiological Society
 Hellenic College of Cardiology
 Working Group of Haemodynamic and Interventional Cardiology
 Working Group of Ηeart Valve Disease, Adult Congenital Heart Disease and
Pulmonary Hypertension
 European Association of Percutaneous Interventions (EAPCI & EAPCI young)
 European Association of Cardiovascular Imaging (EACVI & EACVI club 35)
 Scientific Council, Hygeia Hospital
 Medical Asssociation, Hygeia Hospital
Accreditation pending
Course Directors
Stratis Pattakos, Director, 2nd Cardiothoracic Department, Hygeia Hospital
Konstantinos Spargias, Director, Department of Transcatheter Heart Valves, Hygeia
Hospital
Organizing Committee/Faculty
Stamatis Adamopoulos, Athens
Dimitrios Aggouras, Athens
Dimitrios Alexopoulos, Patras
Aias Antoniadis, Athens
Michalis Argyriou, Athens
Maria Aronis, Athens
George Athanassopoulos, Athens
Michael F Bellamy, London
Georgios Bobotis, Thessaloniki
Nikolaos Bouboulis, Athens
Antonios Chalapas, Athens
Stavros Chatzimiltiadis, Thessaloniki
Eleni Chantzinikolaou, Thessaloniki
Michael Chrissoheris, Athens
Charis Costopoulos, London
Petros Danias, Athens
Petros Dardas, Thessaloniki
Spyridon Deftereos, Athens
Alexis Dimas, Athens
Periklis Davlouros, Patras
G Filippatos, Athens
Parashos Geleris, Thessaloniki
Nikolaos Georgakopoulos, Athens
Georgios Georgiou, Cyprus
Julia Grapsa, London
Georgios Hahalis, Patras
Ioannis Iakovou, Athens
Nikolaos Kafkas, Athens
Stavros Kaliafas, Athens
Bernard Iung, Paris
K Karali, London
George Karatassakis, Athens
Stilianos Konstantinidis, Athens
Georgios Latsios, Athens
J Lekakis, Athens
Alistair Lindsay, London
Savvas Loizos, Athens
Georgios Makavos, Athens
Athanassios Manginas, Athens
Antonios Manolis, Athens
Labros Michalis, Ioanina
Christos Mourmouris, Athens
John Nanas, Athens
Petros Nihoyannopoulos, London
Dimitrios Nikas, Ioanina
Ioulia Nikolaou, Athens
Vlassis Ninios, Thessaloniki
Georgios Ikonomopoulos, Athens
Iakovos Pandeliadis, Athens
Aris Panou, Athens
John Parisis, Athens
Sotirios Patsilinakos, Athens
Athanassios Pipilis, Athens
Vlassis Pirgakis, Athens
Antonios Pitsis, Thessaloniki
Leonidas Poulimenos, Athens
Stylianos Pyxaras, Essen
Sotiris Prapas, Athens
Dimitrios Sionis, Athens
Petros Sfyrakis, Athens
Anastasios Spanos, Athens
Georgios Stavridis, Athens
Emmanuil Skalidis, Crete
Konstantinos Stratos, Athens
Konstantinos Toutouzas, Athens
Konstantinos Triandafyllou, Athens
Athanassios Trikas, Athens
Konstantinos Tsioufis, Athens
Apostolos Tsolakis, Athens
Afroditi Tzifa, Athens
Apostolos Tzikas, Thessaloniki
Dimitrios Tziakas, Alexandroupoli
Manolis Vavouranakis, Athens
Vassilios Voudris, Athens
Antonios Ziakas, Thessaloniki
ADVANCED COURSE ON TRANSCATHETER THERAPIES OF STRUCTURAL HEART DISEASES
Learning objectives
Current and expanding indications for THVT
Planning and organizing THVT
Case selection and screening
Imaging modalities in planning and performing THVT
THVT: Scientific workshops
THVT: Clinical workshops
Challenging cases and difficult scenarios
Avoiding and managing complications
Access site planning
New devices and future THVT
Target Attendees
Cardiologists
Cardiac Surgeons
Heart Team Members
Anesthesiologists
Vascular Surgeons
Radiologists
Intensivists
Nephrologists
Pulmonologists
Echocardiographers
Cathlab and Hybrid Room Nurses
Researchers
Content
Lectures, Debates, Taped Cases, Live Cases
Contact
THVgreece.com, [email protected]
Tel +30 210 6867229-904
Preliminary Program
May 14, 2015
9.00-11.40 Interventions in Structure Heart Disease
Chairman: Professor J Lekakis, Athens University; Professor B Iung, Bichat University Hospital,
Paris
9.00 – 9.30: The future of new subspecialties in structural heart disease together with
cardiovascular imaging
J Grapsa (Imperial College NHS Trust, London / Chair of EACVI club 35)
9.30 – 9.45: Structural heart disease : what the trainee needs to be aware of ?
K Spargias (Hygeia Hospital, Athens)
9.45 – 10.15: Imaging in structural heart disease
M Chrissoheris (Hygeia Hospital, Athens)
10.15-10.30: The TAVI and Mitraclip procedures
A Halapas (Hygeia Hospital, Athens)
10.30-10.45 Structural Heart Disease training in Europe
B Iung
10.45-11.00 Structural Heart Disease training provisions in Greece
J Lekakis
11.00-11.10 Discussion
11.10-11.20 Break
11.20 -13.30 Simulator training
11.20– 13.30: Hands on training on simulators (all TAVI devices and Mitraclip)
13.30-16.20 Interesting cases presented by Trainees and Young Cardiologists I
13.30– 14.00: Case 1 – presented by S Pyxaras (Essen, Germany / EAPCI young committee
member)
14.00 – 14.30: Case 2 – presented by C Costopoulos (Imperial College NHS Trust & Cambridge
University)
14.30 – 15.00: Case 3 – presented by K Karali (Imperial College NHS Trust & AHEPA Hospital)
15.00 – 15.30: Case 4 – presented by S Loizos (Ippokrateio Hospital, Athens)
Comments by: K Spargias, S Pattakos, M Chrissocheris, J Grapsa, P Nihoyannopoulos, MF
Bellamy, and B Iung
15.30-17.00 Break and Simulator Training
17.00-17.30 Honorary Lecture
President: J Grapsa
The role of non-invasive imaging in structural heart interventions
Professor Michael H Picard. Director of Clinical Echocardiography, Massachusetts General
Hospital, Harvard University, Boston, USA
17.30-18.45 Interesting cases presented by Trainees and Young Cardiologists II
17.30 – 18.00: Case 5 – presented by TBA. (Cardiology Department, Bichat University Hospital,
Paris-on behalf of Professor A Vahanian)
18.00 – 18.30: Case 6 – presented by Alistair Lindsay (Royal Brompton Hospital)
18.30 – 19.00: Case 7 – presented by George Makavos (Attiko Hospital)
Comments by: K Spargias, S Pattakos, M Chrissocheris, J Grapsa, P Nihoyannopoulos, MF
Bellamy, and B Iung
May 15, 2015
9.00 – 11.00 Patient screening and selection for TAVI and TAVI case
Moderator: S Pattakos
Panellists: I Mantas, N Kafkas, A Pipilis, C Alexiou (S Konstantinidis)
9.00-9.15 How to screen patients for TAVI today. The minimum common denominators
M Chrissoheris
9.15-9.30 High risk patients should unanimously undergo TAVI. I agree
K Spargias
9.30-9.45 High risk patients should unanimously undergo TAVI. I disagree
M Aronis
9.45-10.15 Patient selection for TAVI: guidelines and future challenges
Professor B Iung, Bichat University Hospital, Paris
10.15-11.00 Live Case and discussion
11.00 - 11.15 Inaugural Greetings
S Pattakos, Conference Organizer
G Zacharopoulos, President of Hygeia Medical Association
A Kartapanis, Manager of Hygeia Hospital
G Bobotis, President of the HCS WG Haemodynamic and Interventional Cardiology
K Tsioufis, President Elect, HCS
11.15-11.30 Break
11.30 – 14.00 Patient screening and selection for Mitraclip and Mitraclip case
Moderator: P Nihoyannopoulos
Panellists: J Parisis, K Spargias, G Stavridis, S Adamopoulos (J Nanas)
11.30-11.50 How I select patients for Mitraclip therapy? M Chrissoheris
11.50-12.10 What to expect from Mitraclip therapy in patients with DMR? V Ninios
12.10-12.30 Mitraclip for patients with advanced HF and FMR. Reasonable for all? M Bellamy
12.30-12.50 What is the surgical option for the patients selected for Mitraclip today? A Pitsis
12.50-13.05 Post mitral intervention – What to measure and how to do it. M Bellamy
13.05-14.00 Live case and discussion
14.00 – 14.30 Break
14.30 – 16.00 Other structural interventions
Moderator: A Tzifa
Commentators: C Ntellos, V Thanopoulos, M Kiafa, F Mitropoulos
14.30-14.50 PFO and ASD closure, when and how. A Tzifa
14.50-15.10 Stenting in Aortic Coarctation. When and how. S Ramos
15.10-15.30 Pulmonary and tricuspid transcatheter valve implantation. V Thanopoulos
15.30-15.45 PVL closure. A Chalapas
15.45-16.00 Transcatheter LAA occlusion, when and how. A Tzikas
16.00-16.10 Other current and future structural interventions. TBA
16.10-16.15 Discussion
16.15 – 16.30 Break
16.30 – 19.00 TAVI industry pipelines and cases in a box
Moderator: V Voudris
Panellists: P Davlouros, A Dimas, M Skalidis, M Papadakis (G Georgakopoulos)
16.30-16.45 How to perform and analyze MCST before TAVI (including OSIRIS and 3MENSIO).
C Mourmouris
16.45-17.00 Medtronic pipeline, M Vavouranakis
17.00-17.15 Edwards pipeline, K Spargias
17.15-17.30 BSC pipeline. J George, Israel
17.30-17.45 St Jude pipeline. A Tzikas
17.45-18.00 Step by step TAVI device selection. TBA
18.00-18.10 Discussion
18.10-19.00 Selection of interesting cases X3 (D Nikas, G Siasos, G Latsios, D Synetos, A
Zacharoulis, G Hahalis, I Iakovou, D Tsikaderis, A Manginas, D Katristis, Ant Manolis, S
Chatzimiltiadis, G Karavolias, G Katsamaklis, C Kotulas, E Skalidis)
May 16, 2015
9.00 – 11.00 TAVI debates and TAVI live case
Moderator: V Pirgakis
Panellists: D Iliopoulos, G Ikonomopoulos, G Bobotis, S Patsilinakos (D Sionis)
9.00-9.15 Who is the inoperable patient and are they all suitable for TAVI? A Zacharoulis
9.15-9.30 TAVI in Greece today. Centers, volumes, trends and financial implications. C
Kotoulas
9.30-9.45 Moderately high risk patient. TAVI is already here! K Toutouzas
9.45-10.00 Moderately high risk patient. TAVI? Never! M Argyriou
10.00-10.10 Discussion
10.10-11.00 Live case and discussion.
11.00 - 11.30 Break
11.30 – 14.00 Mitraclip debates and Mitraclip live case
Moderator: G Filippatos
Commentators: K Triandafyllou, P Danias, P Dedeilias, P Sfirakis (G Athanassopoulos)
11.30-11.45 Patients with HF on optimal treatment and FMR should undergo Mitraclip. I
agree. K Spargias
11.45-12.00 Patients with HF on optimal treatment and FMR should undergo Mitraclip. I
disagree. A Manginas
12.00-12.15 High risk DMR patients should undergo Mitraclip. I agree. P Dardas
12.15-12.30 High risk DMR patients should undergo Mitraclip. I disagree. A Panou
12.30-12.40 Discussion
12.40-13.30 Live case and discussion.
13.30 – 14.00 Break
14.00 – 16.00 TAVI unresolved issues and live case
Moderator: A Spanos
Commentators: I Pandeliadis, S Deftereos, A Trikas, S Pereas (G Karatassakis)
14.00-14.15 TAVI in bicuspid AVS. A Antoniades
14.15-14.30 TAVI in patients with CAD. I Iakovou
14.30-14.45 TAVI in low gradient AVS (low or normal EF). L Poulimenos
14.45-15.00 TAVI ViV. G Karavolias
15.00-15.15 Conduction abnormalities and implications. L Papavassiliou
15.15-16.00 Live case and discussion.
16.00 – 16.30 Break
16.30 – 19.00 TAVI unresolved issues and cases in a box
Moderator: L Michalis
Panellists: E Chatzinikolaou, A Ziakas, S Prapas, D Tziakas (V Lozos)
16.30-16.45 Vascular access for TAVI. The interventional Cardiologist experience. G Georgiou
16.45-17.00 Vascular access for TAVI. The vascular Surgeon experience. S Kaliafas
17.00-17.15 Surgical access for TAVI. The CT surgeon experience. N Bouboulis
17.15-17.30 Who and where should be doing TAVI? D Aggouras
17.30-17.45 TAVI in special patients subsets (PHT, MR, anemia, low PLT, stroke, COAD, CRF,
cirrhosis). G Latsios
17.45-18.00 TAVI devices durability. What we know and what we still have to learn? K Spargias
18.00-18.10 Discussion
18.10-19.00 Selection of interesting cases x3 (D Nikas, G Siasos, G Latsios, D Synetos, A
Zacharoulis, I Iakovou, G Hahalis, D Tsikaderis, A Manginas, D Katristis, Ant Manolis, S
Chatzimiltiadis, G Karavolias, G Katsamaklis, C Kotulas, E Skalidis)
Device simulators will be available for hands on practise during breaks throughout the
meeting